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Abstract 
Aim 
To compare the long-term clinical and radiological results of metal-on-
polyethylene hybrid total hip replacement (THA) with metal-on-metal 
Birmingham hip resurfacing (BHR) in young, active patients. 
Patients & Methods 
From the first consecutive 63 hips in young, active patients who underwent 
BHR by the senior author, 54 (51 patients) were matched to patients who had 
undergone THA with regard to age, gender, body mass index and pre-
operative levels of activity. Radiologically, all hips were assessed for migration 
and osteolysis, THAs for polyethylene wear and BHRs for a pedestal sign. 
Patient reported outcomes, mortality and revision rates were compared. 
Results 
The mean follow-up of the patients with a hybrid THR was 19.9 years and for 
those with a BHR, 17.6 years. 13 patients with a hybrid THR and 5 with a 
BHR had died. The revision rate of the hybrid THRs was 14/54 and of the 
BHRs 6/54. Log rank comparison of Kaplan-Meier survival estimates 
demonstrated a significantly lower mortality in the BHR group (p=0.039; 
Hazard Ratio=0.37 (95% CI=0.15,0.95)) but a non-significant difference in 
revision rates (p=0.067; Hazard Ratio=0.43 (95% CI=0.18,1.06)). The BHRs 
recorded superior OHS (p=0.03), UCLA (p=0.0096), and EuroQol visual 
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analogue scores (p=0.03). Significantly more BHRs had run, played sport and 
undertaken heavy manual labour in the month preceding follow up. 
Conclusion 
After 18 years, patients with BHRs reported superior patient reported outcome 
measures and remained more active with a lower mortality rate but no 
significant difference in revision rates. Both groups demonstrated progressive 
radiological changes at long-term follow-up. 
 
 
 
 
 
 
 
 
 
Introduction 
Hip resurfacing (BHR) was proposed as an alternative to THR in the young 
active population. It was introduced in the 1990s to address the problem of 
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poor implant survival in this population group with hip replacements of the 
time1. 
 
The incidence of hip resurfacing peaked in 2006 with an implantation rate of 
10.8% of all UK hip replacements. Current latest registry data indicates that 
this has now fallen to 0.7%2. This has largely been due to complications 
related to metal on metal bearings and pseudo-tumour formation3. 
 
However registry data shows that its’ 13-year survival is amongst the lowest 
revised (10.1%) in males >55-years2. Originating centres report survival of 
94.1-95.8% at 15-years with good to excellent results4,5. Individual non-
designer centres report 13-year survival of 88.8-92.4%6,7. Registry data 
reports BHR survival of 89.9% at 13-years2 and 90.4% at 15-years8. 
 
This report represents the 18-year follow up of this patient group. This study 
compares the long-term outcome of 54 BHRs from a single surgeon series 
(GCB), with a matched group of hybrid THAs. We have previously reported 
early9, 5-year10 and 10-year11 results of these cohorts in which BHR was 
functionally superior both in terms of hip OHS and activity levels. 
The aim of this study was to see if the superiority of the BHR persists with 
longer-term follow-up. 
 
Patients and Methods 
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Matching 
The BHRs were matched with hybrid THRs for gender, age at surgery (>5 
years), BMI (>5 kg/m2) and their pre-operative level of activity before it was 
limited by symptoms. Activity was graded using the University of California, 
Los Angeles (UCLA) activity score12. We matched patients within 2 points on 
the scale. The mean age of the patients with a BHR at initial arthroplasty was 
49.8 years (18 to 67), their mean BMI was 25.7 kg/m2 (19.7 to 35.1) and their 
mean pre-operative UCLA activity score was 9.0 points (6 to 10). The mean 
age of the patients with a hybrid THR was 50.4 years (21 to 66), their mean 
BMI 27.0 kg/m2 (18.5 to 37.0) and their mean pre-operative UCLA activity 
score was 8.9 points (6 to 10). 
 
Patients 
From August 1999 to April 2001, 63 hips were resurfaced using the BHR 
(previously Midland Medical Technologies, Birmingham, United Kingdom, now 
Smith & Nephew, Memphis, Tennessee). This comprised a cemented femoral 
component and an uncemented hemispherical flanged hydroxyapatite- and 
porous-coated acetabular cup. In no cases did the senior author decide at 
operation that a case was unsuitable for resurfacing and perform a THR 
instead. Of the 63 hips, 2 were revised for fracture of the femoral neck within 
6 weeks of implantation and 1 for avascular necrosis after 1 year. There were 
6 patients (6 hips) who could not be contacted, leaving 54 surviving BHRs in 
51 patients (11 women, 13 hips and 40 men, 41 hips). 
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From January 1996 to April 2001, 54 hips in 53 patients (13 women, 13 hips 
and 40 men, 41 hips) underwent a hybrid THA with a cemented CPT femoral 
component (Zimmer, Warsaw, Indiana) and an uncemented acetabular cup 
and a polyethylene liner. The acetabular components were 29 Harris-Galante 
II (Zimmer), 16 ABG II (Stryker Orthopedics, Mahwah, New Jersey), 7 
Zweymuller (PLUS Orthopedics, Rotkreuz, Switzerland), 1 PFC (DePuy 
International, Leeds, United Kingdom) and 1 Hedrocel (Implex Corp, 
Allendale, New Jersey). A 28 mm modular metal femoral head was used in 45 
hips and a ceramic head in 9. 
Surgery 
The operations were predominantly for primary osteoarthritis9-11. All were 
performed through the posterior approach, which was extensile in the BHRs. 
No hybrid THRs had required further surgery following their primary procedure 
before recruitment to the study. All patients were allowed to fully weight bear 
immediately post-operatively. Patients with BHRs commenced high-impact 
activity after three months but those with hybrid THRs were advised to avoid 
heavy manual work and high impact sport. 
Follow-up 
All patients were invited to attend outpatient clinics, where they completed a 
questionnaire recording complications of their hip arthroplasty, the UCLA 
activity score12, the Oxford hip score (OHS)13, and the EuroQol14 quality of life 
score. The UCLA activity score was used, as previously, with modifications for 
the British population9-11. The OHS was ranked from 12 (asymptomatic) to 60 
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(severe) to allow comparison with previous scores9-11. The EuroQol EQ-5D 
scores were derived from the questionnaire validated for the United Kingdom 
(UK TTO value set)14. 
Patients were asked to classify their running, sporting activity and heavy 
manual work within the last 4 weeks into the following categories: no trouble 
at all, very little trouble, moderate trouble, extreme trouble, tried but 
impossible and not attempted. They were asked to record their satisfaction 
with the surgery as delighted, pleased, satisfied, a little disappointed and very 
disappointed. These measures of activity and satisfaction are not validated. 
The medical notes were checked to ensure that no complications or re-
operations had been missed. The early complications have been reported 
previously9-11.  
Anteroposterior (AP) and lateral radiographs of each hip were taken and 
compared with the previous ones. Changes around the femoral and 
acetabular components of the hybrid THRs were described on the AP 
radiographs using the zones of DeLee and Charnley15 and Gruen, McNeice 
and Amstutz16 and on the lateral radiographs using the additional zones of 
Johnston et al17. Linear polyethylene wear was measured by the method of 
Dorr and Wan18. Radiological changes around the femoral component of the 
BHRs were recorded according to the pedestal sign classification (Table 1)9-
11. Changes around the acetabular component in the BHRs were recorded as 
for the hybrid THRs. 
Statistical analysis  
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The distribution of the data was assessed using the Kolmogorov-Smirnov test. 
The period of follow up was normally distributed and is therefore described 
with the mean and standard deviation. The rest of the data was not normally 
distributed and therefore non-parametric tests were used. The Mann-Whitney 
U test was used to compare postoperative UCLA activity score, OHS, EQ-
VAS, and EQ-5D. The Chi squared test was used to assess categorical data; 
responses to the questionnaire on participation in running, sport, heavy 
manual labour and overall satisfaction with the surgery. OHS was the primary 
outcome measure using a minimum clinically important difference of 5 
points19. The Wilcoxon ranked-pairs test was used for paired comparisons of 
OHS and UCLA activity scores with the previous studies9-11 within each group. 
As the data was non-parametric it was described with the median and inter-
quartile ranges. Survival analysis for revision and mortality outcomes was 
performed using Kaplan-Meier estimates and rates were compared between 
groups with a log-rank (Mantel-Cox) test. Hazard ratios and 95% confidence 
intervals (CI) were calculated. OA p-value of <0.05 was considered 
significant.   
 
 
 
Results 
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Mean follow-up was 17.6 years (Standard Deviation (SD)=0.53) and 19.9 
years (SD=) for BHRs and THRs respectively. Of the BHRs, 5 patients had 
died, 6 had been revised, 4 refused follow up but remained unrevised and 3 
were lost to follow-up, leaving 35/54 non-revised BHRs available for review. 
Of the hybrid THRs, 14 had been revised, 13 patients had died and 1 was lost 
to follow-up, leaving 26/54 non-revised THRs available for review. (Figure 1). 
The medical records of the patients who had died or were lost to follow-up 
indicated satisfactory clinical performance at last review.  
Functional Outcome Scores 
The median OHS for BHRs was 13 (IQR 12-18) (p=0.03) and for hybrid THRs 
was 21 (IQR 13-27) at latest follow up. Superior OHS has been maintained at 
all time points that these cohorts have been compared (Figure 2)9-11. The 
median UCLA activity score was 8 (IQR 6-10) and 6 (5-7) (p=0.01) for BHRs 
and THAs respectively. There was no significant change in either since last 
follow up11. During the 4 weeks before review, more patients with a BHR ran 
(p=0.007), participated in sport (p=0.01) and carried out heavy manual work 
(p=0.002) than patients with a THA (Table 3). Satisfaction was higher in the 
BHR group with 91% (32/35) being either delighted or pleased compared with 
56% (15/26) of the hybrid THR group (p=0.002) (Table 4).   
Revisions 
14/54 (28%) hybrid THRs have been revised, 13 for osteolysis and 1 for 
recurrent dislocation. The osteolysis involved the femur only in zone 7 in 1 
case, the acetabulum only in 7 cases (zone 2 only (4), zone 2 and zone 1 (1), 
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zone 2 and zone 3 (2)). Both the femur and acetabulum were involved in 6 
cases, all in zone 7 on the femur and zone 2 in the acetabulum. An identical 
revision procedure was performed in these patients. To avoid further 
polyethelene wear, the bearing surfaces were changed to ceramic-on-
ceramic. As ceramic liners were not available for the original acetabular 
shells, the shell was exchanged for a Trident component (Stryker 
Orthopaedics). Similarly, as neither a ceramic head nor appropriate trunnion 
adapter was available for the CPT stem, this was revised to an Exeter 
(Stryker Orthopaedics) cement-in-cement revision component, as the cement 
mantle was uniformly good in all cases. Areas of osteolysis in the proximal 
femur at zones 1 and 7 and in the acetabulum were bone-grafted. 
The previous study11 identified 8 THRs with pain, wear and osteolysis at 10 
years with the intention of revision. All cases had acetabular osteolysis. Since 
then, 5 of these have undergone revision surgery. The final 3 remain under 
observation and have not progressed in terms of wear. 
At 18 years of follow up, there were 13 subjects remaining at risk in the BHR 
group and 19 in the THR group. Kaplan-Meier estimates revealed survivorship 
for the outcome of revision to be 88% (95% CI 75.9,94.6) in the BHR cohort 
and 74% (95% CI 59.4,84.0) in the THR cohort (Figure 4). Log-rank test 
revealed that these differences approached but were not significant 
(p=0.067). The hazard ratio of revision in the BHR cohort was 0.43 (95% CI 
0.18,1.06) when compared to the THR cohort. 
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Table 2 records hybrid THR revisions according to the acetabular component 
and type of head. The Harris-Galante components account for the highest 
failure rate when compared to previous follow up11. 
Potential Revisions 
Of 35 remaining BHRs, 4 reported pain with activity. Their OHSs were 6, 35, 
40 and 48. Their pedestal signs at 10-years were 2, 3, 2 and 2, which have 
not progressed.  There was no evidence of infection in any case and all have 
been investigated with either ultrasound scan or MRI with no evidence of 
pseudo-tumour. 11/35 in total of the BHRs have been investigated with MRI 
with no evidence of pseudo-tumour. 
 
Mortality 
At 18 years of follow up, Kaplan-Meier estimates revealed survivorship for the 
outcome of mortality to be 90% (95% CI 77.8,95.8) in the BHR cohort and 
71% (95% CI 54.8,82.9) in the THR cohort (Figure 5). Log-rank test revealed 
that these differences were significant (p=0.039). The hazard ratio of mortality 
in the BHR cohort was 0.37 (95% CI 0.15,0.95) when compared to the THR 
cohort. 
Radiological Outcomes 
7 BHRs were unable to attend for radiographs but completed a postal 
questionnaire. Their current OHSs were 12, 12, 12, 13, 16, 17 and 18.  Of 
these patients, all had undergone radiological examination at 7,7, 8, 8, 11, 12 
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and 35 months before completing the questionnaires, which were used for 
comparison, these were at a mean of 14.5 years since implantation. Mean 
time to radiographic evaluation of the complete cohort was 15.3 years (Table 
5).   
The pedestal sign which had previously been assessed at last follow up11 had 
not progressed in 33/35 cases (Figure 3).  
7 hybrid THAs were unable to attend for radiographs assessment but 
completed a postal questionnaire. Their OHSs were 21, 21, 22, 25, 26, 32 and 
42. All had radiographs at 20, 23, 26, 31, 54, 60 and 69 months before 
completing the questionnaires respectively (mean 15.1 years). Mean 
radiological follow up for the entire cohort was 16.2 years (range 12-20). 
24/26 of the remaining hybrid THAs demonstrated progressive linear wear 
(mean 1.7mm, 0-2.6). There was evidence of periarticular osteolysis in 15 in 
association with polyethylene wear, 13 had lysis in Gruen zones 1 or 7. 
Lucent lines around the femoral component were noted in these cases but all 
corresponded with the areas of lysis in zones 1 or 7. There were no cases 
with lucent lines distal to these proximal zones. In 4 there was also 
periacetabular osteolysis with 2 further having isolated acetabular osteolysis. 
Lucent lines were seen around the acetabular component in 16 of the 
remaining hybrid hips. No component had migrated. Stem subsidence 
remained stable since last review11. 
Discussion 
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Our study demonstrates superior patient reported outcomes and activity levels 
in those patients who underwent BHR rather than THA. At mean clinical follow 
up of 18 years in both groups median OHS and UCLA activity score were 
significantly higher. Significantly more of those with a BHR ran, played sport 
and undertook heavy manual work in the month preceding their latest follow 
up. Despite a trend toward better survival in the BHR group, this did not reach 
statistical significance. Radiological changes remained static in both groups.  
Registries report revision rates of BHRs at 6.9%8 and 9%20 at 10-years, 9.9% 
at 12-years2 and 9.6% at 15-years8. Designing centres report revision rates of 
5.9% at 14-years5 and 4.2% at fifteen-years4. 10-year independent centre 
revision ranges from 5-13%21-23. Our results display a similar rate of revision 
of 11% at 16-years. 
Metal-on-polyethylene hybrid THAs have a 13-year registry revision rate of 
11.05% in males less than 55 years2. We report a higher revision rate of 27% 
in our cohort at 16 years. This may be explained by several factors; 
recruitment was performed before highly-cross-linked polyethylene which may 
improve survival24, air irradiation of polyethylene liners used, young age at 
implantation and low revision threshold by the senior author due to the 
general progression of osteolysis experienced with these components25. Our 
cohort included older generation uncemented acetabular components, which 
have reported high revision rates at 15 years25. The majority of patients, 
although demonstrating a degree of progressive radiological change, remain 
symptom free and remain under observation. 
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Comparative studies of BHR and THA are report largely short and medium 
time periods only. Several report quality of life or improved functional 
outcomes associated with resurfacings1,11,26-32, others however report no 
difference in scores but did not assess activity levels33-35. Costa et al35 report 
no difference in either Oxford or Harris Hip scores at 12 months in their 
prospective randomised study of 126 patients. Our study reports outcomes at 
16 years that is longer than these studies and includes data on activity 
specific functions. Superior function in this cohort has been maintained at 510, 
1011 and 16 years.  
Haddad et al36 report their series of young patients at 12 years who had either 
undergone BHR or cementless THA with a metal-on-highly cross-linked 
polyethylene bearing surface using a 32mm head. They report similar results 
of higher functional outcomes in patients who received a BHR despite similar 
patient aspirations and consider they have experienced a ceiling effect. Their 
wear and osteolysis rates are significantly lower but this may well be related 
to the better polyethylene and acetabular components used in their series. In 
our series, the introduction of ceramic head in 9 of the hybrid THAs in our 
series did not seem protective of cup failure, however numbers were too low 
to provide statistical significance. There are contemporary hybrid THRs that 
have shown improved survivorship in the early to medium term in comparison 
to the implants used in this study37,38. 
In this series, BHR revisions were due to femoral component failure and THA 
by acetabular component failure. There were no CPT stem failures and this 
proves to be a reliable implant in younger patients39. Despite early failures 
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suggesting the BHRs would show progressive radiographic changes with the 
risk of subsequent failure, this has not occurred. Since last review11 only 1 
further BHR failure has occurred and the remainder are functioning well 
without significant radiographic progression. No pseudo-tumours have been 
identified which is an identified risk in this implant group3. 
Strengths of this study are that although recruitment was retrospective, the 
data analysed have been collected prospectively. The groups are well 
matched and this has not been distorted by loss to follow up. Follow up is 
longer than any currently published series of this type. The limitations of this 
study are that it is not randomised and subject to selection bias. Patients with 
a BHR had no activity restrictions, whereas those with a THA did, although 
37%, disregarded the restrictions suggested9. In the young, active population 
hip scoring systems may have a ceiling effect40. Many of our patients 
achieved the maximum possible score. The use of other qualitative questions 
in our study has concurred with the significant difference in OHS.  
MoM bearings pose concerns with potential for deleterious effects in relation 
to the bearing couple and increased revision rates3,20,41 but we have shown 
that this is not reflected in a significant difference in mortality or revision rates 
in this cohort. Improved functional outcomes in the BHR group suggest this is 
an option still worth considering in appropriately selected patients and the lack 
of a significant difference in revision and mortality is reassuring but this must 
be considered in the context of the selection bias that is likely to have 
occurred in this and other studies.  
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THA survival in the under 50s has been reported as low as 60% in registry 
data42. At 15 years we have demonstrated that BHRs remain more active and 
superior in function to the hybrid THRs with no increase in revision or mortality 
rates.  Hip resurfacing remains a valid option for younger male, active patients 
with end stage osteoarthritis. 
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Tables 
43.  
Table 1. Classification of radiological appearance of femoral component after 
resurfacing 
 
 
Table 2. Distribution of components and revision rates at a mean follow-up of 
19.9 years in the hybrid total hip replacement group 
 
 
 
 
Table 3. Participation in activities in the previous four weeks (number of hips) 
 
Activity Group Trouble      
  None 
Very 
Little Moderate Extreme Impossible 
Not 
attempted 
Running Hybrid 1 1 0 0 5 20 
 BHR 8 4 0 1 4 18 
        
Sports Hybrid 5 2 1 0 4 15 
 BHR 14 7 2 0 2 10 
        
Heavy manual labour Hybrid 1 3 1 0 6 16 
 BHR 13 3 5 0 1 13 
 
 
 
Classification 
type Radiological Appearance 
0 No change 
1 Pedestal sign but no migration 
a Sclerotic line confined to curved tip of stem 
b Sclerotic line confined to distal 1cm of shaft of stem 
c 
Sclerotic line +/- symmetrical lucent lines, extending proximally beyond 
distal 1 cm of shaft  
2 Migration, usually into varus with asymmetrical lucent lines 
3 Displaced fracture 
Acetabular 
component Head type 
Numbe
r 
Decease
d Revised 
Harris-Galante Metal 26 5 9 
Harris-Galante Ceramic 3 0 2 
Zweymuller Metal 7 3 1 
ABG Metal 10 3 1 
ABG Ceramic 6 0 1 
PFC Metal 1 1 1 
Hydrocel Metal 1 0 0 
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Table 4. Patient satisfaction with the prostheses (number of hips, %) 
  
 
Group Delighted Pleased Satisfied Disappointed  
    A Little A Lot 
Hybrid 14(52) 1(4) 5(18) 6(22) 1(4) 
BHR 26(74) 6(17) 0 (0) 2(6) 1(3) 
 
 
 
Table 5. Radiological appearances and revisions for patients with Birmingham 
hip resurfacing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Status 
Five years 
(%) 
Nine 
years (%) 
Fifteen 
years (%) 
Loss to follow up or 
death 1 6 9 
Declined radiographs 1 3 4 
    
Radiological appearance   
Type 0 16 (30.8) 4 (8.9) 8 (19.5) 
Type 1a 6 (11.5) 4 (8.9) 6 (14.6) 
Type 1b 16 (30.8) 8 (17.8) 5 (12.2) 
Type 1c 9 (17.3) 19 (42.2) 11 (26.8) 
Type 2 5 (9.6) 5 (11.1) 4 (9.8) 
Type 3/Revised 0 5 (11.1) 7 (17.1) 
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Figure Legends 
Figure 1. Oxford Hip Scores of both cohorts at different time points of review. 
 
Figure 2. Kaplan-Meier estimate for revision of the construct (95% Confidence 
intervals) 
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Figure 3. Kaplan-Meier curve for patient survival (95% Confidence intervals) 
 
 
Figure 4. Typical changes around BHR femoral component that have 
remained stable since last review. 
 
 
